Tennessee Rybelsus Stomach Paralysis Lawsuit (2024 Update)

Quick Summary

• If you’ve experienced stomach paralysis as a result of taking Rybelsus in Tennessee, you’re likely seeking answers. This article cuts to the chase, offering you the latest on the Tennessee Rybelsus stomach paralysis lawsuit, insight into eligibility for compensation, and a guide to navigating the legal path ahead.
• If you or someone you know has faced complications from using Rybelsus, Schmidt & Clark, LLP, is here to assist. Renowned for representing plaintiffs, our mission is to secure the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by offering free, confidential case evaluations for potential clients with claims related to stomach paralysis from medications like Rybelsus. Schmidt & Clark (S&C) is a law firm that specializes in pharmaceutical litigation.

With our extensive experience, S&C is dedicated to advocating for plaintiffs in these complex lawsuits and providing the legal support they need to navigate the intricacies of their claims.

Our firm can assist you in the following ways:

• Offering free, confidential case evaluations to assess your claim.
• Providing expert legal representation tailored to your specific needs.
• Ensuring your rights are protected and pursuing the compensation you deserve.

Rybelsus Stomach Paralysis Lawsuit

Tennessee has seen an increase in legal actions against the manufacturers of Rybelsus, primarily due to stomach paralysis experienced by users. These lawsuits claim that diabetic drugs like Rybelsus have caused gastrointestinal problems, including gastroparesis, which can lead to symptoms like vomiting and abdominal pain.

Individuals who have taken Rybelsus or other GLP-1 RA treatments and suffered from stomach paralysis are coming forward to file lawsuits. Notably, around 20 lawsuits have targeted Novo Nordisk and Eli Lilly, including a case involving a diabetic woman from Louisiana. This wave of litigation underscores the need for affected patients to seek legal recourse and hold the pharmaceutical companies accountable.

Beyond individual plaintiffs, these lawsuits contribute to a broader narrative, highlighting the health complications these drugs can induce. As the legal environment continues to evolve, staying updated is important for those affected by these medications.

What Is Rybelsus?

According to Healthline, Rybelsus is a medication used to help individuals with type 2 diabetes mellitus control high blood sugar levels. It is one of the options for those taking diabetic drugs. The drug works by mimicking the effects of GLP-1, a hormone that helps regulate blood sugar levels [1].

Administered in oral tablet form, Rybelsus slows down digestion, making users feel fuller for longer periods, which can aid in weight management.

However, select groups face an elevated risk of stomach paralysis, particularly patients who weren’t adequately warned about the medication’s severe side effects. Gaining an understanding of Rybelsus and its functioning is key to grasping the lawsuits it has instigated.

How Does Rybelsus Work?

Rybelsus works by containing the active ingredient semaglutide, which is a GLP-1 receptor agonist (GLP-1 RA). This ingredient helps improve blood sugar control in patients with type 2 diabetes and can also promote weight loss. The primary objective of GLP-1 RA medications is to keep blood sugar levels under control, a vital aspect of diabetes management.

However, while these medications offer significant benefits, they are also more likely to cause gastrointestinal side effects, such as gastroparesis, compared to other weight loss drugs. This dual nature of the medication—providing substantial benefits but also posing serious risks—underpins many of the lawsuits being filed against the weight loss drug.

Rybelsus Side Effects and Symptoms

Research has linked semaglutide medications like Rybelsus to an elevated risk of developing gastroparesis, a condition where the stomach does not empty properly, commonly referred to as stomach paralysis.

This condition can lead to a range of debilitating symptoms, including nausea, vomiting, and severe abdominal pain.

According to Mayo Clinic, diagnosis of gastroparesis can be complex and typically involves various tests, such as [2]:

• Blood and urine tests for infections or kidney problems
• Upper GI series or abdominal ultrasounds to reveal obstructions
• Different stomach emptying tests that use radioactive materials or breath analysis

Both patients and healthcare providers must comprehend these side effects.

Rybelsus FDA-Approval and Its Black Box Warning

According to the agency, Rybelsus received FDA approval on September 20, 2019, for use in adults with type 2 diabetes mellitus. The medication contains semaglutide and comes with a black box warning from the FDA regarding the risk of thyroid cancer [3].

However, the warning does not cover the risk of gastroparesis, a significant oversight given the number of patients reporting severe gastrointestinal issues.

This lack of adequate warnings has led to numerous lawsuits against Novo Nordisk and Eli Lilly, the manufacturers of Rybelsus. Patients contend that the lack of adequate warnings regarding potential life-threatening side effects like stomach paralysis from these companies could have swayed their decision to use the drug.

How Do You Qualify for a Rybelsus Stomach Paralysis Lawsuit?

To qualify for a Rybelsus stomach paralysis lawsuit, you must have taken the medication Rybelsus, experienced severe stomach paralysis or gastroparesis, and provided evidence from a healthcare professional establishing a connection between the condition and the use of Rybelsus.

If Rybelsus was used for weight loss and led to severe side effects requiring medical intervention, you might qualify for a lawsuit. To fortify your case, key evidence such as medical records, prescription proof, and documentation of medical treatments is required.

Rybelsus carries a boxed warningTrusted Source about the risk of thyroid cancer. This is the most serious alert from the FDA – Ami Patel PharmD, BCPS, Pharmacist at UNC Health

The Status Of The Rybelsus Stomach Paralysis Litigation in Tennessee

As of February 2024, Tennessee is part of an ongoing Multidistrict Litigation (MDL) class action lawsuit involving Rybelsus and related drugs. These proceedings are under the jurisdiction of U.S. District Judge Karen Marston in Philadelphia. A plaintiff fact sheet is being developed to uniformly collect injury reports from the numerous plaintiffs represented in this mass tort MDL.

A ‘Science Day’ is scheduled to provide a comprehensive understanding of the medical and scientific issues central to the Rybelsus litigation. Plaintiffs argue that relying solely on gastric emptying studies is insufficient to establish causation for their injuries from Rybelsus.

Rybelsus Lawsuit Settlement Amounts in Tennessee

Settlement amounts for stomach paralysis cases in Tennessee can vary significantly, typically ranging from $400,000 to $700,000, depending on the severity of the injury and its impact on the patient’s life. The compensation is determined by the extent of the illness and how it has affected the individual’s daily life and well-being.

These settlements aim to cover medical expenses, lost wages, and the pain and suffering endured by the affected individuals. For those suffering from severe illnesses related to gallbladder complications or other severe side effects, the settlement amounts can be substantial.

Filing a Rybelsus Stomach Paralysis Lawsuit in Tennessee

Filing a Rybelsus lawsuit in Tennessee involves several steps, including gathering evidence, understanding legal strategies, and being aware of the statute of limitations. A Nashville-based law firm is currently involved in a class-action lawsuit targeting pharmaceutical companies for the side effects associated with drugs like Rybelsus.

Filing a lawsuit requires thorough documentation and legal representation. Patients who have developed stomach paralysis after using Rybelsus should consult with legal experts to navigate the complexities of their case and ensure that all necessary evidence is presented effectively.

Legal Strategies and Challenges

Legal strategies in Rybelsus lawsuits focus on:

• Establishing causation
• Proving that the manufacturer failed to warn about the risks of gastroparesis adequately
• Arguing that common side effects like nausea, diarrhea, and headaches may mask more serious conditions like stomach paralysis.

Plaintiffs claim that drug companies made incomplete or misleading statements about the safety of their products and failed to inform patients about the potential for severe gastrointestinal problems. The legal proceedings aim to hold these pharmaceutical companies accountable for their negligence.

Types of Evidence To Present

Evidence for a Rybelsus lawsuit includes a detailed timeline of events, medical records, and documentation of treatments and surgeries related to stomach paralysis. It is crucial to note when Rybelsus was first prescribed and when symptoms began.

Gathering all relevant medical records, including:

• prior medical history
• diagnostic tests
• doctors’ notes
• emergency room visits
• hospital admissions
• follow-up treatments

This documentation helps demonstrate the link between Rybelsus use and the development of stomach paralysis. Compiling it strengthens your case.

What is the Statute of Limitations for a Rybelsus Lawsuit in Tennessee?

The statute of limitations for a Rybelsus lawsuit in Tennessee is generally one year from the date the injury was discovered, with a maximum limit of three years after the event.

However, certain exceptions apply, such as cases involving fraud or concealment, where the one-year limitation applies from the discovery date without a set time limit for the occurrence of the event.

Related Articles:

• Saxenda Lawsuit
• Weight Loss Drug Stomach Paralysis Attorney
• Wegovy Stomach Paralysis Litigation

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our Tennessee Rybelsus Lawyers

The Schmidt & Clark, LLP law firm is here to support you during challenging times. If you or a loved one has suffered from complications due to medications such as Rybelsus, don’t hesitate to contact us.

Our team has extensive experience handling such cases and will guide you through the legal proceedings. We’ll clarify your rights and assess your eligibility for a lawsuit related to these complications.

Get a free case evaluation, and remember, we only charge fees if we successfully win your case. You can trust that our commitment to your case is as strong as if you were part of our own family. Contact us today for a comprehensive review of your concerns.

Reference:

1. https://www.healthline.com/nutrition/how-to-get-rybelsus
2. https://www.mayoclinic.org/diseases-conditions/gastroparesis/diagnosis-treatment/drc-20355792
3. https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-glp-1-treatment-type-2-diabetes